The microscope collects fluorescence from successive optical sections through an intact cell, tissue, or organoid. These depth-resolved images preserve the relative positions of labeled structures and can be combined into a three-dimensional reconstruction. The resulting map shows where a molecular marker occurs throughout the specimen rather than only where it appears in a single viewing plane.
Fluorescently labeled antibodies bind their intended molecular markers, producing signals that distinguish those structures from surrounding material. This binding-based contrast allows researchers to associate observed fluorescence with particular proteins or other targets. Interpretation therefore depends on relating the detected signal to the marker being localized within the preserved three-dimensional specimen.
By retaining spatial relationships across specimen depth, the method can show how immune cells are organized, where pathogens are located, and how microbes interact with host cells. It also helps visualize tissue penetration, linking molecular-marker distribution with the physical arrangement of infected or inflamed tissue.
A typical workflow begins with an intact cell, tissue, or organoid and fluorescently labeled antibodies directed toward selected molecular markers. The specimen is then examined by collecting optical sections at successive depths. Those sections are assembled into a three-dimensional view, allowing the distribution and spatial relationships of the labeled targets to be examined.
Researchers can apply the method when the location of immune cells, pathogens, or host and microbial markers matters alongside their molecular identity. It is especially relevant for examining immune-cell organization, infection-related tissue penetration, and host-microbe interactions. These observations can clarify how infection and inflammation are spatially arranged within intact biological material.
Three-dimensional distributions of molecular markers provide spatial measurements that can be used in biomarker analysis and in evaluating vaccines or antimicrobial therapies. For infection and inflammation studies, the maps can connect treatment-related changes with pathogen localization, immune organization, or tissue penetration, helping researchers assess outcomes in their original spatial context.